TrialThrombosis and haemostasis2024

Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene Elaparvovec.

Debra D Pittman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.